As of Oct 08
| -0.14 / -2.46%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 16.50, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a +196.76% increase from the last price of 5.56.
The current consensus among 5 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.